{"id":24551,"date":"2021-11-04T18:54:22","date_gmt":"2021-11-04T22:54:22","guid":{"rendered":"https:\/\/archive.fcomnow.com\/2021\/sponsor\/novartis-pharmaceuticals\/"},"modified":"2021-11-04T18:54:24","modified_gmt":"2021-11-04T22:54:24","slug":"novartis-pharmaceuticals","status":"publish","type":"sponsor","link":"https:\/\/archive.fcomnow.com\/2021\/sponsor\/novartis-pharmaceuticals\/","title":{"rendered":"Novartis Pharmaceuticals"},"content":{"rendered":"<p>Xolair is the first biologic for the treatment of nasal polyps that targets and blocks immunoglobulin E (IgE), a key driver of inflammation. Xolair is FDA-approved across three diseases and in two formulations, continuing to build on the medicine&#8217;s 17 years of patient experience since its initial approval for allergic asthma.<\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-24551","sponsor","type-sponsor","status-publish","hentry"],"acf":{"airtable_id":"recwQxuvMUc1RTtUU","sponsor_name_id":"Novartis Pharmaceuticals-74","sponsor_id":"74","sponsor_name":"Novartis Pharmaceuticals","tagline":"","sponsor_type":"ENT","sponsor_logo":"novartis-logo.svg (https:\/\/dl.airtable.com\/.attachments\/b02f995bb16a32b24003b8bcbcf39eaa\/ea280ce8\/novartis-logo.svg)","sponsor_url":"www.novartis.com","sponsor_description":"Xolair is the first biologic for the treatment of nasal polyps that targets and blocks immunoglobulin E (IgE), a key driver of inflammation. Xolair is FDA-approved across three diseases and in two formulations, continuing to build on the medicine's 17 years of patient experience since its initial approval for allergic asthma.","sponsor_level":"Bronze","sponsor_status":"Active","sponsored_sessions":"","facebook":"https:\/\/www.facebook.com\/novartis","twitter":"https:\/\/twitter.com\/novartis","instagram":"https:\/\/www.instagram.com\/novartis\/","youtube":"","linkedin":"https:\/\/www.linkedin.com\/company\/novartis\/","booth_number":"19","contact_email_address":"nicole.mccard@novartis.com <nicole.mccard@novartis.com>","banner":""},"day":null,"duration":null,"end_date":null,"end_time":null,"session_code":null,"session_description":null,"session_id":null,"session_name":null,"session_objectives":null,"session_type":null,"session_type_detail":null,"society":null,"start_date":null,"start_time":null,"test_speaker_link":null,"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Novartis Pharmaceuticals - FCOM<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/archive.fcomnow.com\/2021\/sponsor\/novartis-pharmaceuticals\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novartis Pharmaceuticals - FCOM\" \/>\n<meta property=\"og:description\" content=\"Xolair is the first biologic for the treatment of nasal polyps that targets and blocks immunoglobulin E (IgE), a key driver of inflammation. Xolair is FDA-approved across three diseases and in two formulations, continuing to build on the medicine&#8217;s 17 years of patient experience since its initial approval for allergic asthma.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/archive.fcomnow.com\/2021\/sponsor\/novartis-pharmaceuticals\/\" \/>\n<meta property=\"og:site_name\" content=\"FCOM\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-04T22:54:24+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/archive.fcomnow.com\/2021\/sponsor\/novartis-pharmaceuticals\/\",\"url\":\"https:\/\/archive.fcomnow.com\/2021\/sponsor\/novartis-pharmaceuticals\/\",\"name\":\"Novartis Pharmaceuticals - FCOM\",\"isPartOf\":{\"@id\":\"https:\/\/archive.fcomnow.com\/2021\/#website\"},\"datePublished\":\"2021-11-04T22:54:22+00:00\",\"dateModified\":\"2021-11-04T22:54:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/archive.fcomnow.com\/2021\/sponsor\/novartis-pharmaceuticals\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/archive.fcomnow.com\/2021\/sponsor\/novartis-pharmaceuticals\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/archive.fcomnow.com\/2021\/sponsor\/novartis-pharmaceuticals\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/archive.fcomnow.com\/2021\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novartis Pharmaceuticals\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/archive.fcomnow.com\/2021\/#website\",\"url\":\"https:\/\/archive.fcomnow.com\/2021\/\",\"name\":\"FCOM\",\"description\":\"Florida Combined Otolaryngology Meeting\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/archive.fcomnow.com\/2021\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novartis Pharmaceuticals - FCOM","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/archive.fcomnow.com\/2021\/sponsor\/novartis-pharmaceuticals\/","og_locale":"en_US","og_type":"article","og_title":"Novartis Pharmaceuticals - FCOM","og_description":"Xolair is the first biologic for the treatment of nasal polyps that targets and blocks immunoglobulin E (IgE), a key driver of inflammation. Xolair is FDA-approved across three diseases and in two formulations, continuing to build on the medicine&#8217;s 17 years of patient experience since its initial approval for allergic asthma.","og_url":"https:\/\/archive.fcomnow.com\/2021\/sponsor\/novartis-pharmaceuticals\/","og_site_name":"FCOM","article_modified_time":"2021-11-04T22:54:24+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/archive.fcomnow.com\/2021\/sponsor\/novartis-pharmaceuticals\/","url":"https:\/\/archive.fcomnow.com\/2021\/sponsor\/novartis-pharmaceuticals\/","name":"Novartis Pharmaceuticals - FCOM","isPartOf":{"@id":"https:\/\/archive.fcomnow.com\/2021\/#website"},"datePublished":"2021-11-04T22:54:22+00:00","dateModified":"2021-11-04T22:54:24+00:00","breadcrumb":{"@id":"https:\/\/archive.fcomnow.com\/2021\/sponsor\/novartis-pharmaceuticals\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/archive.fcomnow.com\/2021\/sponsor\/novartis-pharmaceuticals\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/archive.fcomnow.com\/2021\/sponsor\/novartis-pharmaceuticals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/archive.fcomnow.com\/2021\/"},{"@type":"ListItem","position":2,"name":"Novartis Pharmaceuticals"}]},{"@type":"WebSite","@id":"https:\/\/archive.fcomnow.com\/2021\/#website","url":"https:\/\/archive.fcomnow.com\/2021\/","name":"FCOM","description":"Florida Combined Otolaryngology Meeting","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/archive.fcomnow.com\/2021\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/archive.fcomnow.com\/2021\/wp-json\/wp\/v2\/sponsor\/24551","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/archive.fcomnow.com\/2021\/wp-json\/wp\/v2\/sponsor"}],"about":[{"href":"https:\/\/archive.fcomnow.com\/2021\/wp-json\/wp\/v2\/types\/sponsor"}],"wp:attachment":[{"href":"https:\/\/archive.fcomnow.com\/2021\/wp-json\/wp\/v2\/media?parent=24551"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}